roquefortinvest.com | Home - Roquefort Therapeutics

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php

Meta Tags

Title	Home - Roquefort Therapeutics
Description	Skip to content Menu Menu Home About Us Board & Senior Management Our Strategy Midkine What is Midkine Extensive Research Drug Development International C
Keywords	N/A

Server Information

WebSite	roquefortinvest.com
Host IP	185.230.63.171
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

roquefortinvest.com Valuation

US$1,005

Last updated: 2022-07-03 04:13:45

roquefortinvest.com has Semrush global rank of 0. roquefortinvest.com has an estimated worth of US$ 1,005, based on its estimated Ads revenue. roquefortinvest.com receives approximately 116 unique visitors each day. Its web server is located in -, with IP address 185.230.63.171. According to SiteAdvisor, roquefortinvest.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,005
Daily Ads Revenue	US$0
Monthly Ads Revenue	US$27
Yearly Ads Revenue	US$334
Daily Unique Visitors	7
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
roquefortinvest.com.	A	3599	IP: 185.230.63.171
roquefortinvest.com.	A	3599	IP: 185.230.63.107
roquefortinvest.com.	A	3599	IP: 185.230.63.186
roquefortinvest.com.	NS	86400	NS Record: ns0.wixdns.net.
roquefortinvest.com.	NS	86400	NS Record: ns1.wixdns.net.
roquefortinvest.com.	MX	3600	MX Record: 0 roquefortinvest-com.mail.protection.outlook.com.

HtmlToTextCheckTime:2022-07-03 04:13:45

Skip to content Menu Menu Home About Us Board & Senior Management Our Strategy Midkine What is Midkine Extensive Research Drug Development International Collaborations Investors Regulatory News Share Capital Information Corporate Governance Advisors Corporate Documents Shareholder Documents Financial Reports Presentations Research Reports Contact Menu Home About Us Board & Senior Management Our Strategy Midkine What is Midkine Extensive Research Drug Development International Collaborations Investors Regulatory News Share Capital Information Corporate Governance Advisors Corporate Documents Shareholder Documents Financial Reports Presentations Research Reports Contact Roquefort Investments Roquefort Therapeutics is a LSE Main Market listed biotech company developing products through the pre-clinical phase prior to partnering or selling to big pharma. The Company is focused on developing first in class Midkine inhibiting RNA therapeutic drugs for the treatment of cancer, chronic

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Thu, 28 Oct 2021 04:37:05 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.roquefortinvest.com/
strict-transport-security: max-age=120
Age: 33811
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: 6ivkWfREES4Y8b2pOpzk7Owfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkViozyX1iilefXjG31S4IO7n,m0j2EEknGIVUW/liY8BLLjPDFZzqr/nlb7YyA5Dm8UkMbwluI1yUDJty9McxOlfY,2d58ifebGbosy5xc+FRalmETnIvW+upWPFHuwAMMD59Z1OMFIUf7JzwIAKpxwIGxSROjWPqNalLIehTnu9JLvQ==,2UNV7KOq4oGjA5+PKsX47O2a5xgRLfGhgyjJBLXaH1ZYgeUJqUXtid+86vZww+nL
Cache-Control: no-cache
X-Wix-Request-Id: 1635395825.3685601819631110278
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Thu, 28 Oct 2021 04:37:05 GMT
content-type: text/html; charset=UTF-8
content-length: 341417
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"2f04ff725d6eaa353b9b1fe80f89a61a"
content-language: en
strict-transport-security: max-age=120
age: 22246
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMclMQzbR0A/m5vNbgNVf0Qw,qquldgcFrj2n046g4RNSVGuzUR+ZX0KpeYRQjJYRPxRYgeUJqUXtid+86vZww+nL,2d58ifebGbosy5xc+FRaloxSUcRMZC0SmXWUKyPryyv+SPtCq2oQ10UXNPA8l9PpSf524lPwTgDbn82fURSkbmrGoQYNt6gnPAu2JbQpk4w=,2UNV7KOq4oGjA5+PKsX47MuWjC1KFhNR/NziahEGFwtYgeUJqUXtid+86vZww+nL
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1635395825.51255884094213201
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=usc1_g; Max-Age=20; Expires=Thu, 28 Oct 2021 04:37:25 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=usc1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

roquefortinvest.com Whois Information

Domain Name: ROQUEFORTINVEST.COM
Registry Domain ID: 2560526358_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.domain.com
Registrar URL: http://www.domain.com
Updated Date: 2020-10-23T10:38:58Z
Creation Date: 2020-09-18T07:38:08Z
Registry Expiry Date: 2022-09-18T07:38:08Z
Registrar: Domain.com, LLC
Registrar IANA ID: 886
Registrar Abuse Contact Email: compliance@domain-inc.net
Registrar Abuse Contact Phone: 602-226-2389
Domain Status: ok https://icann.org/epp#ok
Name Server: NS0.WIXDNS.NET
Name Server: NS1.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-15T22:19:51Z <<<

roquefortinvest.com valuation and analysis